Pharmaceutical industry news

NCT06362928: Safety and Effectiveness of the Akura Thrombectomy System in the Treatment of Acute Pulmonary Embolism

Study type: INTERVENTIONAL. Phase: NA.

NCT06313398: Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

NCT06181344: Implementation and Evaluation of a Fear of Cancer Recurrence Screening, Referral and Management Program

Study type: INTERVENTIONAL. Phase: NA.

NCT06075810: A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

NCT06023199: Assessing Physical Function in Sickle Cell Patients Taking Voxelotor

Study type: INTERVENTIONAL. Phase: PHASE2.

NCT06019000: Study of CYR-064 Versus Placebo in Patients.

Study type: INTERVENTIONAL. Phase: PHASE2.

NCT05896839: Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

NCT05391321: Identification of the Most Suitable Questionnaire to Assess the Sexual Function of Women Living in France After Colorectal Cancer Surgery

Study type: INTERVENTIONAL. Phase: NA.

NCT05226494: Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma

Study type: INTERVENTIONAL. Phase: PHASE1.

NCT04633252: A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

NCT04538664: A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT04201873: Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma

Study type: INTERVENTIONAL. Phase: PHASE1.

NCT04172532: Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

NCT04086485: Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

NCT03480633: Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure

Study type: OBSERVATIONAL. Phase: .

NCT02769949: Pediatric Patients With Metabolic or Other Genetic Disorders

Study type: OBSERVATIONAL. Phase: .

NCT02257736: An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT01834001: Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy

Study type: OBSERVATIONAL. Phase: .

NCT01678222: The COX-2 Gene and the Immune System

Study type: OBSERVATIONAL. Phase: .

NCT01143454: Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Study type: OBSERVATIONAL. Phase: .

NCT01087294: Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

Study type: INTERVENTIONAL. Phase: PHASE1.

NCT00923065: Data Collection, Clinical Care and Interventions in CCR, NCI

Study type: OBSERVATIONAL. Phase: .

NCT00895271: Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders

Study type: OBSERVATIONAL. Phase: .

NCT00837122: Genetics of Type 2 Diabetes in West Africans

Study type: OBSERVATIONAL. Phase: .

NCT00339495: Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial

Study type: OBSERVATIONAL. Phase: .

NCT00026650: Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy

Study type: OBSERVATIONAL. Phase: .

JW Jungwoo Pharmaceutical Launches First Expansion Product "Ice Crunch" under Frenz Brand

BioMarin (BMRN) Stock Looks To Trade At A Discount To Fair Value

José Javier Fuster recibe el ESC Outstanding Achievement Award 2026

‘Don’t kill a mosquito with a sword’; court warns of ‘stinging orders’, contempt action and jail as FDA withdraws orders against Cipla

FDA approves new use of popular diabetes drug

The Pain In NYC's Biotech Market Is Hitting Harlem Hardest

Bukwang boosts H1 revenue past 100b won as Latuda targets Korea depression market - CHOSUNBIZ

Lilly’s Brenipatide Steps Into Phase 3: A New Long-Term Play in Depression Care

Tenax Therapeutics (TENX) Reports Promising Phase 3 Trial Data A

Tenax Therapeutics announces results from Phase 3 LEVEL trial of TNX-103

Maharashtra FDA Seizes FDC Enerzal Stock Over Misbranding Allegations

FDA approves Protagonist and Takeda’s drug for rare blood cancer

Is It Too Late to Buy Moderna Stock After Its 127% Surge?

UNCY Stock Crashed 45% Today – Why Did FDA Reject Its Kidney Disease NDA For A Second Time?

Biotech Stocks To Keep An Eye On - August 30th

Bombay HC pulls up Maharashtra FDA over enforcement actions: What businesses need to know

PDT Partners takes $3.35M stake in West Pharmaceutical as earnings beat estimates

Cipla's Drug License Cancelled Over Reactin Plus, Then Restored: Why Did Bombay HC Pull Up Maharashtra FDA?

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia

SK Bio Broadens U.S. Prospects, Licensing Late-Stage Epilepsy Drug From Biohaven

‘Don’t kill a mosquito with a sword’; court warns of ‘stinging orders’, contempt action and jail as FDA withdraws orders against Cipla

Evotec stock holds at $1.91 as analysts stick to a hold view

India Must Move From ‘Pharmacy to Laboratory of the World’: Anupriya Patel

Why Australia needs better PBS transparency frameworks

Europe Pharmaceutical Drying Equipment Market Size, Share,Trends, Growth Analysis Report, 2029

Bombay HC Pulls Up Maharashtra FDA Over Cipla Licence Cancellation, Says ‘You Are Going Overboard’

Bombay HC pulls up Maharashtra FDA over enforcement actions: What businesses need to know

CNA938 Rewind - Impact of planned Trump tariffs on pharmaceutical imports

Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings

ACI’s 6th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA

Induction prog held at MGM's Dept of Pharmaceutical Sciences

What Is Teva Pharmaceutical Industries (TEVA) Gaining From This Bankruptcy Drug Deal?

“Do You Feel You Are A Lord?” Bombay HC Pulls Up Tukaram Mundhe-Led FDA

September Rebalancing Predictions for Yuanta Taiwan Top 50 ETF: PharmaEssentia Poised to Become Sole Biotech Constituent; King Yuan Electronics and Two Others Face Removal Risk